3) Kodani E, Atarashi H, Inoue H et al : Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Non-valvular Atrial Fibrillation : A Subanalysis of the J-RHYTHM Registry. J Am Heart Assoc 5, 2016.
7) Fang MC, Go AS, Chang Y et al : A new risk scheme to predict warfarin-associated hemorrhage : The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 58 : 395-401, 2011.
20) Katoh H, Nozue T, Asada T et al : Frequency and predictors of bleeding complications associated with anti-coagulant therapy using dabigatran in Japanese patients with atrial fibrillation. Am J Cardiovasc Dis 4 : 70-78, 2014.
22) Westenbrink BD, Alings M, Granger CB et al : Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation : Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J 185 : 140-149, 2017.